Aspen Pharmacare. Down 37% From 3rd & Final Sell Call
The final call was on the peak of 29 September. Looking back, good call (hope it helped!).
Down 37% From 3rd & Final Sell Call.
Updates 1 to 3 attached.
Down 37% From 3rd & Final Sell Call.
Updates 1 to 3 attached.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.